National Alliance Securities assumed coverage on shares of Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) in a research note issued to investors on Monday, Analyst Ratings Netreports. The firm issued a buy rating and a $64.22 price target on the stock. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -1.18% in last session and finished the day at $50.90. Traded volume was 500.00million shares in … Continue reading Drug Manufacturer Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Prana Biotechnology (NASDAQ:PRAN), Amarin Corporation (NASDAQ:AMRN), Depomed Inc (NASDAQ:DEPO)